Literature DB >> 12692787

Intermediate basal cells of the prostate: in vitro and in vivo characterization.

Levi A Garraway1, Douglas Lin, Sabina Signoretti, David Waltregny, James Dilks, Nandita Bhattacharya, Massimo Loda.   

Abstract

BACKGROUND: Progenitor cells within the prostate basal layer may play important roles in differentiation and carcinogenesis; however, prostate stem cell populations remain uncharacterized.
METHODS: Immunohistochemical and immunoblot analyses were used to characterize prostate epithelial cells (PrEC), a commercially available prostate basal cell isolate.
RESULTS: Proliferating PrECs exhibited immunophenotypic characteristics most consistent with basal cells, but during senescence PrECs up-regulated androgen receptor (AR) mRNA, p27, and low-molecular-weight cytokeratin (LMWCK) expression, suggestive of partial differentiation. PrECs also stained strongly for involucrin, which marked a subset of intermediate prostate basal cells in vivo. Basal hyperplasia consisting of involucrin-positive cells was prevalent in prostate tissue from androgen-ablated patients, and formed epithelial clusters flanked by involucrin-negative basal and luminal monolayers. Cultivation of PrECs on matrigel together with androgen-treated stromal conditioned media resulted in dense aggregates, with a peripheral rim of basal-like cells expressing p63 and basal cytokeratins.
CONCLUSIONS: PrEC represents an epithelial population whose basal characteristics are modified in response to matrigel, stromal factors, and senescence, consistent with a transient amplifying population. These cells may derive from a previously unrecognized, involucrin-positive subset present in vivo. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692787     DOI: 10.1002/pros.10244

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  29 in total

Review 1.  Stem cells in prostate cancer initiation and progression.

Authors:  Devon A Lawson; Owen N Witte
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  The impact of genomic alterations on the transcriptome: a prostate cancer cell line case study.

Authors:  J Chaudhary; M Schmidt
Journal:  Chromosome Res       Date:  2006-07-12       Impact factor: 5.239

3.  Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells.

Authors:  Ivan V Litvinov; Donald J Vander Griend; Yi Xu; Lizamma Antony; Susan L Dalrymple; John T Isaacs
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

4.  The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.

Authors:  Donald J Vander Griend; Wouter L Karthaus; Susan Dalrymple; Alan Meeker; Angelo M DeMarzo; John T Isaacs
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

5.  A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression.

Authors:  Pradip K Majumder; Chiara Grisanzio; Fionnuala O'Connell; Marc Barry; Joseph M Brito; Qing Xu; Isil Guney; Raanan Berger; Paula Herman; Rachel Bikoff; Giuseppe Fedele; Won-Ki Baek; Shunyou Wang; Katharine Ellwood-Yen; Hong Wu; Charles L Sawyers; Sabina Signoretti; William C Hahn; Massimo Loda; William R Sellers
Journal:  Cancer Cell       Date:  2008-08-12       Impact factor: 31.743

Review 6.  Prostate epithelial stem and progenitor cells.

Authors:  Oh-Joon Kwon; Li Xin
Journal:  Am J Clin Exp Urol       Date:  2014-10-02

7.  Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor.

Authors:  Li Xin; Michael A Teitell; Devon A Lawson; Andrew Kwon; Ingo K Mellinghoff; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

8.  Expression of the IGF axis is decreased in local prostate cancer but enhanced after benign prostate epithelial differentiation and TGF-β treatment.

Authors:  Petra Massoner; Michael Ladurner Rennau; Isabel Heidegger; Anita Kloss-Brandstätter; Monika Summerer; Eva Reichhart; Georg Schäfer; Helmut Klocker
Journal:  Am J Pathol       Date:  2011-10-06       Impact factor: 4.307

Review 9.  The potential of organoids in urological cancer research.

Authors:  Shangqian Wang; Dong Gao; Yu Chen
Journal:  Nat Rev Urol       Date:  2017-05-23       Impact factor: 14.432

Review 10.  Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.

Authors:  Murielle Mimeault; Parmender P Mehta; Ralph Hauke; Surinder K Batra
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.